POSA244 First-Line Maintenance (1L MT) Treatment of Stage IV Non-Small Cell Lung Cancer (NSCLC) in Western Europe (WE): Results of the CancerMPact® Survey 2020

O Clark, G Kanas,L Kalilani,L Durbin, K Nersesyan, K Keeven,TJ Giove, J Chao,A Aziez, C Hogea,A Stojadinovic

Value in Health（2022）

引用 0|浏览3

暂无评分

摘要

Treatment (Tx) decisions for metastatic NSCLC are complex. Our aim is to describe results of a physician survey (CancerMPact®) from WE in 2020, focusing on first-line (1L) and maintenance (1L MT) Tx of stage IV NSCLC without driver mutations.

查看译文

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要